USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/21183
Full metadata record
DC FieldValueLanguage
dc.contributor.authorStavila, Ecaterina-
dc.date.accessioned2022-06-16T10:51:49Z-
dc.date.available2022-06-16T10:51:49Z-
dc.date.issued2022-
dc.identifier.citationSTAVILA, Ecaterina. Assessment of quality of life in COPD patients with comorbidities. In: MedEspera: the 9th International Medical Congress for Students and Young Doctors: abstract book. Chișinău: S. n., 2022, p.154.en_US
dc.identifier.urihttps://medespera.asr.md/en/books?page=1-
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/21183-
dc.description.abstractIntroduction. Chronic obstructive pulmonary disease (COPD) continues to be one of the leading causes of death and health-care cost worldwide. The majority of patients have at least one comorbid condition of clinical significance. Aim of study. Study of comorbidities in chronic obstructive pulmonary diseases. Methods and materials. The study was conducted in 75 patients with COPD. Comorbidities were assessed by Charlson comorbidity index (CCI). Health-related quality of life was assessed by the Clinical COPD Questionnaire (CCQ), COPD Assessment Test (CAT) and St. George Respiratory Questionnaire (SGRQ). Spirometric data were analyzed (FEV1, FVC, FEV1/FVC). Results. 75 COPD patients were studied, mean age was 59.2±6.5 years, mean FEV1, % was 36.6±13.3%. Patients across all stages of the GOLD classification had similar age and pack/years (p>0.01). Charlson comorbidity index (CCI) had a moderate negative correlation with 6MWD (r=-0.39, p<0.01) and absence correlation with the rate of exacerbations (r=0.15, p=0.01). CCI had a moderate correlation with SGRQ activity (r=0.39, p<0.01), impact (r=0.38, p<0.001) and total (r=0.38, p<0.001) scores. Questionnaires for assessing the quality of life when applied to assess the risk of comorbidities showed unsatisfactory discriminatory power (SGRQ AUC - 0.4, CCQ AUC - 0.44 and CAT AUC - 0.39). Conclusion. COPD is frequently associated with other diseases. Comorbidities have a greater negative impact on COPD patients in terms of quality of life. HRQL questionnaires, when applied to assess the risk of comorbidities showed unsatisfactory discriminatory power.en_US
dc.language.isoenen_US
dc.publisherNicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, Association of Medical Students and Residentsen_US
dc.relation.ispartofMedEspera: The 9th International Medical Congress for Students and Young Doctors, May 12-14, 2022, Chisinau, Republic of Moldovaen_US
dc.titleAssessment of quality of life in COPD patients with comorbiditiesen_US
dc.typeOtheren_US
Appears in Collections:MedEspera 2022

Files in This Item:
File Description SizeFormat 
ASSESSMENT_OF_QUALITY_OF_LIFE_IN_COPD_PATIENTS_WITH_COMORBIDITIES.pdf218 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback